Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial | Zendy

Jeremy Furtado | Zendy; Hannia Campos | Zendy; Anne E. Sumner | Zendy; Lawrence J. Appel | Zendy; Vincent J. Carey | Zendy; Frank M. Sacks | Zendy

Open Access

Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial

Author(s) -

Jeremy Furtado,

Hannia Campos,

Anne E. Sumner,

Lawrence J. Appel,

Vincent J. Carey,

Frank M. Sacks

Publication year - 2010

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.3945/ajcn.2009.28532

Subject(s) - medicine , apolipoprotein b , endocrinology , triglyceride , very low density lipoprotein , cholesterol , lipoprotein , overweight , obesity

Blacks have lower average triglyceride and LDL cholesterol concentrations than do whites but higher rates of coronary heart disease. Apolipoprotein (apo) C-III in VLDL and LDL stimulates atherogenic processes in vascular cells. In blacks, the concentration of lipoproteins with apo C-III is unknown, and the response to dietary strategies that lower triglyceride and apo C-III has not been investigated

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research